Reactive oxygen species and enzyme dual-responsive biocompatible drug delivery system for targeted tumor therapy

Spurred by newly developed drug delivery systems (DDSs), side effects of cancer chemotherapy could be reduced by using multifunctional nanoplatforms. However, the facile synthesis of effective DDSs remains a challenge. Here, a six-arginine-tailed anti-epidermal growth factor receptor (EGFR) affibody...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Control Release
Autors principals: Zhao, Ning, Ding, Bingbing, Zhang, Ying, Klockow, Jessica L., Lau, Ken, Chin, Frederick T., Cheng, Zhen, Liu, Hongguang
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006592/
https://ncbi.nlm.nih.gov/pubmed/32450093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2020.05.031
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars